Patents by Inventor Josep M. Llovet

Josep M. Llovet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF HEPATIC DISORDERS
    Publication number: 20110263441
    Abstract: The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating hepatic disorders such as hepatocellular carcinoma and/or cirrhosis. A variety of informative biomarkers corresponding thereto, are provided, wherein alterations in expression relative to a control is correlated with the presence of a hepatic disorder, likelihood of survival from a hepatic disorder, and likelihood of recurrence of a hepatic disorder.
    Type: Application
    Filed: October 15, 2009
    Publication date: October 27, 2011
    Inventors: Todd R. Golub, Yujin Hoshida, Bryan C. Fuchs, Kenneth K. Tanabe, Josep M. Llovet Bayer, Augusto Villanueva
  • Methods and compositions for the diagnosis for early hepatocellular carcinoma
    Patent number: 8030013
    Abstract: Methods and compositions are provide to allow discrimination of dysplastic nodules from early HCC nodules. More specifically, it has been determined that TERT, GPC3, gankyrin, survivin, TOP2A, LYVE1, Ecadherin, IGFBP3, PDGFRA, TGFA, cyclin D1 and HGF are differentially expressed in HCC as compared to normal liver cells and liver cells that have dysplastic, non-cancerous nodules.
    Type: Grant
    Filed: April 13, 2007
    Date of Patent: October 4, 2011
    Assignee: Mount Sinai School of Medicine
    Inventors: Josep M. Llovet, Scott L. Friedman, Myron Schwartz